Premium
Response to Letter: ‘Reply to “High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability?”’
Author(s) -
Pineton de Chambrun M.,
Frere C.,
Miyara M.,
Amoura Z.,
MartinToutain I.,
Mathian A.,
Hekimian G.,
Combes A.
Publication year - 2021
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.13166
Subject(s) - medicine , covid-19 , critically ill , antiphospholipid syndrome , intensive care medicine , critical illness , antibody , betacoronavirus , immunology , virology , disease , infectious disease (medical specialty) , outbreak
Click here to view the Letter to the Editor by Pineton de Chambrun et al.